Beijing Biostar Pharmaceuticals Co., Ltd.
Research Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK) on Bullrun: market cap HKD 1.48B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2563.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyHKD
- Market capHKD 1.48B
- Financial periodFY2025
- RevenueCNY 33.36M
- Revenue growth-53.6%
- Net income-CNY 131.44M
- Free cash flow-CNY 156.94M
- Gross margin92.2%
Valuation Snapshot
latest market cap is HKD 1.48B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 33.36M | -CNY 131.44M | -CNY 156.94M | 92.2% | -0.36 | CNY 456.77M | CNY 1.97M | CNY 666.08M |
| FY2024 | CNY 71.87M | -CNY 143.78M | -CNY 153.39M | 86.4% | n/a | CNY 466.64M | CNY 1.18M | CNY 790.75M |
| FY2023 | CNY 66.64M | -CNY 189.64M | -CNY 178.62M | 70.3% | -0.52 | CNY 38.09M | CNY 899.00K | CNY 723.16M |
| FY2022 | CNY 32.82M | -CNY 160.51M | -CNY 112.12M | 72.8% | -0.44 | CNY 60.11M | CNY 1.90M | CNY 867.93M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.48B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the development, manufacturing, and commercialization of oncology products in the People's Republic of China. The company develops Utidelone injections for metastatic breast cancer, breast cancer neoadjuvant, non-small cell lung cancer, pancreatic cancer, non-small cell lung cancer brain metastasis, and breast cancer brain metastasis indications;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Beijing Biostar Pharmaceuticals Co., Ltd.'s market cap?
Beijing Biostar Pharmaceuticals Co., Ltd.'s market capitalization is HKD 1.48B.
What does Beijing Biostar Pharmaceuticals Co., Ltd. do?
Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the development, manufacturing, and commercialization of oncology products in the People's Republic of China.